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Molecular dynamics simulations have the potential to provide atomic-level detail and insight to important
questions in chemical physics that cannot be observed in typical experiments. However, simply generating a
long trajectory is insufficient, as researchers must be able to transform the data in a simulation trajectory
into specific scientific insights. Although this analysis step has often been taken for granted, it deserves
further attention as large-scale simulations become increasingly routine. In this perspective, we discuss the
application of Markov models to the analysis of large-scale biomolecular simulations. We draw attention to
recent improvements in the construction of these models as well as several important open issues. In addition,
we highlight recent theoretical advances that pave the way for a new generation of models of molecular kinetics.
I. INTRODUCTION
Simulations have the hope to shed light on many ar-
eas in chemical physics. For example, molecular dynam-
ics (MD) simulations, which numerically integrate New-
ton’s equations to simulate physical dynamics, can pro-
vide high-resolution physics-based models of emergent bi-
ological phenomena.1–4 While promising, there are three
central challenges which limit the application of MD for
studying questions in biophysics. The first is the devel-
opment of simplified physical models (called force fields),
which avoid the intractability of solving the full, elec-
tronic Schro¨dinger equation. Second, while simulations
are required to use a discrete time step on the order of one
femtosecond, processes that are characterized by slow,
large-scale, collective motions, such as protein folding,
protein-ligand binding, and conformational change can
take milliseconds or longer to occur. This separation in
timescales requires a simulation of length at least 1012
time steps in order to observe one such event, which is
difficult using current hardware. Finally, the analysis of
MD simulations is itself non-trivial since the result – a
set of trajectories tracking the Cartesian coordinates of
every particle – can contain millions of data points in tens
of thousands of dimensions. Despite these challenges, a
number of recent innovations have expanded the scope of
molecular simulation. In fact, because of improvements
in forcefield accuracy,5–10 and the development of novel
computing platforms,11–15 we believe that quantitative
analysis has increasingly become a limiting factor in the
application of MD.16,17
With routine MD datasets now comprising terabytes
of data, the direct visualization of raw MD trajectories
is neither scalable nor quantitative. Instead, we suggest
that MD trajectories should not be viewed as ends in
and of themselves, but instead a means of parameteriz-
ing a quantitative statistical model of the structure and
a)These two authors contributed equally
dynamics of the system of interest.
These models should have the following properties:
1. The model should be oriented toward quantita-
tively describing the long-timescale processes in the
data.
2. The model should be suitably complex, capable of
smoothly adapting to – rather than assuming – the
structure of the data.
3. The model should be interpretable and provide an-
swers to specific scientific questions that may be
difficult to answer via experiment alone.
Towards this end, we survey recent developments in the
theory and application of Markov modeling for the anal-
ysis of MD simulations, which have all of these desired
properties.
II. LONG TIMESCALES AND THE TRANSFER
OPERATOR
The transfer operator provides a theoretical founda-
tion for the description of the slow dynamical processes
in stochastic systems, and is the basis for the approaches
discussed herein. Indeed, at its essence, the methods
described below all work to build some sort of numer-
ical model of the transfer operator. Here we highlight
some important details; we refer the interested reader to
Schu¨tte, Huisinga, and Deuflhard.18
Consider a time-homogeneous, ergodic Markov pro-
cesses, xt, in phase space, Ω, which is reversible with
respect to a positive stationary density µ(x). At time
t, an ensemble of such processes can be described by a
probability distribution, pt(x), which can change as a
function of time. The evolution of this probability den-
sity over a time interval τ can be described by the action
of an operator, T (τ), the transfer operator. For each
time t, define the equilibrium-weighted probability den-
sity, ut(x) = pt(x)µ(x)
−1. Then T (τ) is defined as the
2operator that evolves ut(x) to ut+τ (x):
ut+τ (x) = T (τ) ◦ ut(x). (1)
T (τ) is bounded and self-adjoint with respect to the
scalar product
〈f, g〉µ =
∫
Ω
dx f(x)g(x)µ(x), (2)
and can therefore be decomposed into terms correspond-
ing to each of its eigenfunctions:
ut+nτ (x) =
[
T (τ)
]n
◦ ut(x) =
∞∑
i=1
λni 〈ψi, ut〉µψi(x), (3)
The eigenvalues, λi, are real, and the eigenpairs
(λi, ψi(x)) can be taken to be sorted in decreasing order
by eigenvalue. According to the Perron-Frobenius theo-
rem, λ1 is equal to one and corresponds to the stationary
eigenfunction, ψ1(x) = 1. The remaining eigenvalues lie
in (−1, 1), and are associated with eigenfunctions which
describe directions of collective motion in phase space
– dynamical processes – along which the system relaxes
towards equilibrium. Eq. (3) can therefore be rewritten
as:
ut+nτ (x) = 1 +
∞∑
i=2
exp
(
−
nτ
ti
)
〈ψi, ut〉µψi(x). (4)
where ti are the characteristic relaxation timescales of
each dynamical mode, defined in terms of the associated
eigenvalues,
ti = −
τ
lnλi
. (5)
At long times (large n), terms in Eq. (3) and Eq. (4)
corresponding to large eigenvalues (long relaxation
timescales) dominate the summation, as small-eigenvalue
modes equilibrate and decay quickly. The focus for ac-
curate numerical models of T (τ) is thus to resolve these
dominant eigenmodes.
The fundamental approach we will take is to use com-
putational methods to build an approximate representa-
tion of the transfer operator, T (τ), from molecular dy-
namics simulations in a way which is systematic, auto-
mated, and statistically rigorous. One major upshot of
this approach is that it allows a wide range of simulation
data to be useful, ranging from many relatively short tra-
jectories (compared to the longest timescales of interest)
to a few long trajectories. Below, we lay out the chal-
lenges, current status, and future of this paradigm.
III. METHODS
A. Markov State Models
Markov State Models (MSMs) describe the stochastic
dynamics of molecules as a Markovian jump process be-
tween a finite number of conformational states. Because
of the Markov property, the probability of jumping to a
new state only depends on the current state. As such,
the dynamics are completely determined by a transition
matrix, T, such that
Tij = P (xt+τ ∈ sj|xt ∈ si) (6)
where {xt}Nt=1 is a trajectory in Ω and the states, S =
{si}ki=1, are a set of non-overlapping subsets of Ω that
partition the space: si ⊆ Ω ∀ i, ∪ki=1si = Ω, si ∩ sj =
∅ ∀ i 6= j. T is a discretization of T ,
Tij =
∫
sj
dxµ(x)(T ◦ 1si)∫
si
dxµ(x)
, (7)
where
1si(x) =
{
1 x ∈ si
0 x /∈ si
(8)
There is a rich history of describing the dynamics of
biophysical processes in terms of finite state models, in-
cluding work based on enumeration of potential energy
minima,19,20 study of simplified physical models,21,22
analysis of long-timescale processes from many short
trajectories,23–29 and transition path and spectral analy-
sis of the resulting network models.30–33 For more specific
details on MSMs, we refer the interested reader to Prinz
et al. 34 and Pande, Beauchamp, and Bowman.35
Though the theory is relatively simple, the construc-
tion of an MSM is not a solved problem. Given a set
of MD simulations, we need to define a state decom-
position, S, as well as estimate the transition proba-
bility matrix, T. Straightforward maximum likelihood
estimators for T, given S exist,34,36 but the determina-
tion of S itself is more challenging. A wide variety of
strategies have been proposed for constructing S, includ-
ing grid-based discretization,27 and clustering with many
algorithms36,37 and distance metrics.38–43 However, no
consensus has emerged in the literature on the preferred
strategy, largely because these clustering schemes rest
on heuristic foundations built primarily by physical intu-
ition. No solid theoretical justifications exist for choos-
ing one of these schemes over another, especially when
statistical errors in the parameterization of T are non-
negligable.
On the other hand, Sarich, Noe´, and Schu¨tte 44 showed
that in the absence of statistical uncertainty in the pa-
rameterization of T, an MSM’s error, measured in terms
of the maximum possible difference between the true
and MSM-predicted probability density at a later time,
is bounded. The state decomposition-dependent com-
ponent of this bound quantifies the difference between
the transfer operator’s continuous eigenfunctions, ψi(x),
and the MSM’s piecewise constant approximate eigen-
functions, given by the eigenvectors of T. This result im-
plies that a “good” state decomposition is one that finely
partitions phase space particularly in the regions where
the dominant eigenfunctions, ψi(x), change rapidly, such
3as transition regions or energy barriers. Unfortunately,
these barrier regions are precisely the areas that are most
poorly sampled in MD. Finely subdividing these regions
into many MSM states can lead to large statistical errors
in the associated transition probabilities.
In practice, even the seemingly simple problem of de-
ciding the correct number of states given a clustering
algorithm and distance metric is difficult.39,45 When the
number of states is low, the discretization in Eq. (7) is
very coarse, which leads to systematic underestimation
of the relaxation timescales.44,46 However, as the num-
ber of states increases, we have to estimate more state
to state transition probabilities. With the amount of
data fixed, increasing the number of parameters leads
to a corresponding increase in the statistical uncertainty
of the model. Some recent work, however, has made
progress toward balancing these sources of errors by
defining a likelihood function for evaluating and com-
paring models.39,45 These likelihood functions are useful
for simple systems, but can be difficult to employ in most
MSM applications.
To illustrate the difficulty of building a state space
more concretely, consider a simulation of a protein and a
ligand where we are interested in calculating the on and
off rates of the binding reaction. In this simulation, the
ligand is very mobile when it is not bound to the protein,
and so a typical geometric clustering will produce many
unbound states. These states contribute to the statis-
tical error since we are essentially forcing the model to
describe the diffusion of the ligand in water. However,
since we are only interested in the binding reaction, we
do not care about this diffusion, and could instead build
a more statistically robust MSM by ignoring these mo-
tions in the unbound state. This behavior is not unique
to protein-ligand simulations, and in fact has been an
issue when analyzing protein folding simulations. Typ-
ically these models must use tens of thousands of small
states – termed microstates – in order to accurately de-
scribe the folding reaction’s timescale.47–49 Not only does
this increase the statistical error, but it raises major chal-
lenges for the interpretation of the resulting model. One
suggested resolution has been to lump these microstate
models into coarser macrostate models by grouping to-
gether states which rapidly interconvert.32,33,50,51
In our view, this microstate-to-macrostate lumping
strategy can be dangerous, and we discourage its use.
The lumping procedure relies directly on the quality of
the microstate model, which is purposely estimated sub-
ject to large statistical errors. For example, the PCCA
and PCCA+ algorithms for lumping MSMs are designed
to preserve the estimates of the slow eigenfunctions as
identified by the microstate model,33,50 without regard
to the fact that these estimates are, by design, approxi-
mated subject to large errors. Although other methods
like BACE partially remedy this problem,32,52 in our view
a more direct solution is to construct accurate and inter-
pretable models from the start.
To be able to build simultaneously accurate and in-
terpretable MSMs, clustering must be able to focus
on the important (slowly equilibrating) degrees of free-
dom, while ignoring the unimportant ones. One suit-
able method is thus to perform dimensionality reduc-
tion before clustering, explicitly removing quickly decor-
relating coordinates. With this in mind, Schwantes
and Pande 43 and Pe´rez-Herna´ndez et al. 42 introduced
time-structure based Independent Component Analysis
(tICA) for building MSMs. The tICA method identi-
fies the slowest decorrelating linear projections in the ob-
served data. This technique has made it possible to build
macrostate MSMs from the very beginning that better
resolve long-timescale processes.45,53 In addition, these
models have identified new slow motions that eluded de-
tection previously, such as near-native register shift dy-
namics in β-sheet proteins.43
B. A Generalization of MSMs: Hidden Markov Models
Part of the difficulty in constructing the MSM state
space is that there is no single quantitative criterion for
comparing alternative state spaces which is suitable for
practical applications. Therefore, one approach is to gen-
eralize the MSM method such that the state decomposi-
tion can be optimized simultaneously with the transition
probabilities in a unified way. Hidden Markov models
(HMMs) are one such extension that relax the constraint
that states correspond to a discrete partition of Ω. Like
MSMs, HMMs characterize the system using a Markov
jump process over a finite number of states; however in
the HMM, these states are not assumed to be directly
observed. Instead, each hidden state is equipped with an
emission distribution defined on Ω, describing the per-
state conditional probability of observing a conformation
at a particular point in phase space. HMMs have been
widely used in a variety of fields, including signal pro-
cessing, speech, and bioinformatics.54,55
For example, using Gaussian emissions, if {St ∈
{1 . . . k}}Nt=1 is the Markov chain over hidden states with
transition probability matrix T, {Xt ∈ Ω}Nt=1 is the ob-
served process, pi is a probability vector for the initial
distribution over hidden states, {µi ∈ Ω}ki=1 are the per-
state means, and {Σi}ki=1 are the per-state covariance
matrices, the model can be specified probabilistically as
S1 ∼ Categorical(pi), (9)
St+1 ∼ Categorical(rowSt(T)), (10)
Xt ∼ N (µSt ,ΣSt). (11)
Constructing an HMM requires estimating the tran-
sition probability matrix T as well as the emission dis-
tribution parameters θi = (µi, Σi). Using a maximum-
likelihood approach, T and θi can be estimated jointly.
56
In the HMM, the θi’s are analogous to the MSM’s state
decomposition, but unlike the MSM state space, the θi’s
are determined simultaneously with the elements of T –
the two are jointly optimized with respect to the same
4objective function. In our view, this is the key advantage
of the HMM, as the optimal construction of the MSM
state space remains an unsolved problem.
One caveat in applications of HMMs to analysis of
MD is that without conditioning on St, the HMM’s ob-
served process Xt is strictly non-Markovian when the
emission distributions have nonzero overlap. While it
is precisely these overlaps that make the model (particu-
larly θi) optimizable, they also hamper direct interpreta-
tion of the HMM as a model for the Markovian transfer
operator.57,58
IV. RECENT APPLICATIONS
Markov models have been heavily applied to many
different types of systems, ranging from protein
folding,48,49,59 RNA folding,60 protein-ligand binding,61
and protein conformational change.4,58,62 Below, we sum-
marize two recent highlights from the literature, which
demonstrate the unique utility of Markov modeling. In
particular, these approaches allow researchers to connect
many short MD trajectories into a single coherent de-
scription of the dynamics. Moreover, MSMs are able to
provide an interpretable picture of the kinetics that can
lead to specific scientific insight.
A. β2 Adrenergic Receptor (β2AR) Activation
β2AR is a G-protein coupled receptor (GPCR) in-
volved in many trans-membrane signaling pathways.
GPCRs are critical in medicine, representing the tar-
get for 30% of top-selling drugs on the market.63 De-
spite extensive experimental studies,64–67 the mechanism
of β2AR activation is elusive. Kohlhoff et al.
68 used
Google exacycle, a cloud computing platform that en-
ables scientific calculations to be run on Google’s data-
center infrastructure, to collect over 2 ms of aggregate
MD simulations of β2AR in a lipid bilayer and explicit
solvent using tens of thousands of individual MD trajec-
tories, each with a mean length of ∼ 10 ns. Although
no individual MD trajectory traversed the full activa-
tion pathway, Kohlhoff et al. 68 were able to use MSMs
to understand the full activation landscape using these
many short trajectories. This is a particularly powerful
property of MSMs, because collecting many short trajec-
tories is substantially easier than generating a few long
trajectories.11,69
In addition, Kohlhoff et al. 68 simulated these trajec-
tories in three waves. The starting conformations for the
second and third wave were selected by uniformly sam-
pling states from an MSM built on the previous waves.
Known as adaptive sampling, this technique provides a
framework for efficiently covering all of phase space with
many, relatively short simulations, which is only possible
because of the use of MSMs.70,71
Kohlhoff et al. 68 used the MSM to show that the ac-
tivation of β2AR proceeded along multiple paths. Many
of these pathways featured metastable intermediates that
displayed unique chemotype selectivity in docking stud-
ies, suggesting that computational drug design can be
enhanced by considering important intermediates.
B. β-Lactamase Allosteric Sites
While typical structure-based computational drug de-
sign pipelines use a single protein conformation to screen
for potential therapeutics,72 proteins are dynamic sys-
tems and an ensemble of structures exist in solution. Ac-
counting for this heterogeneity could expand the range of
possible methods for modulating protein activity. With
this in mind, Bowman and Geissler 73 set out to find cryp-
tic druggable binding sites in β-lactamase using MD sim-
ulations and MSMs.
Using one hundred microseconds of aggregate simula-
tion time distributed over hundreds of trajectories, each
no longer than 500 ns, Bowman and Geissler 73 were able
to characterize slow near-native conformational changes
in β-lactamase. Their MSM was able to describe the ki-
netics of the opening and closing of various cryptic bind-
ing sites on distal regions of the protein. In particular,
MSMs allowed the researchers to study the lifetimes and
equilibrium opening probabilities of these pockets. They
first observed that a known cryptic binding site was pre-
dicted to be open 53% of the time according to the MSM.
Furthermore, they identified 50 novel sites, which were
predicted to be open more than 10% of the time, sug-
gesting new avenues for drug design.
V. DISCUSSION
While these results highlight that MSMs have been
useful for analyzing MD simulations, the definition of
the state space remains a substantial hurdle in MSM
construction. Although recent work has provided signifi-
cant improvements in this area, one way to side-step this
challenge is to build a Markov model (i.e. provide an es-
timate of the transfer operator) without using a discrete
state decomposition. Towards this end, Noe´ and Nu¨ske 74
and Nu¨ske et al. 75 established a variational principle that
applies to the estimation of the transfer operator’s eigen-
spectrum. This is analogous to the variational principle
for the Hamiltonian in quantum mechanics and guaran-
tees that, when the operator is discretized using a finite
basis set, its eigenvalues are underestimated in the limit
of vanishing statistical errors.
Given a basis set, the variational approach searches
for linear combinations of basis set elements which ap-
proximate the transfer operator eigenfunctions by solv-
ing a particular generalized eigenvalue problem, or equiv-
alently maximizing a series Rayleigh quotients that can
be interpreted as autocorrelation functions. In fact, the
5MSM approach is a specific instance of this method when
the basis set consists of indicator functions which parti-
tion Ω, but the method more broadly can be applied
to any set of basis functions including those which have
nonzero overlap. Furthermore, tICA is also an instance of
this approach, with a basis set instead consisting of linear
functions of the input coordinates. In the HMM, how-
ever, the process observed in Ω is not strictly Markovian,
and thus its interpretation in terms of the Markovian
transfer operator (or its eigenspectrum) is less straight-
forward.
This theoretical advance suggests a tension between
two distinct but related perspectives for building simpli-
fied models of molecular kinetics:
1. Parameterize a probability distribution over trajec-
tories.
2. Find the first m eigenfunctions of T .
The HMM and tICA methods are certainly dif-
ferent, but to what extent are probabilistically- and
variationally-inspired models distinct? These views are,
at least, not always different since an MSM is both a
probabilistic model and one that estimates the slowest
eigenfunctions of T . But, outside of MSMs, when is
a probabilistic model more desirable than a variational
model, or vice versa? Is one model missing something
that can only be found in the other? If so, is it possible
to unify these views with a model other than an MSM?
We do not know the answers to these questions, but both
perspectives have enriched our understanding of molecu-
lar kinetics, and we anticipate future developments will
clarify the apparent tension and lead to new classes of
Markov models.
VI. CONCLUSIONS
The future of Markov modeling is bright. Ten years
ago, conventional MD simulations could only access
timescales in the nanosecond regime.76 A revolution in
GPU computing,13,69,77 however, has enabled researchers
around the world to perform simulations that were once
impossible. But, MD trajectories alone are not enough.
Quantitative analysis, which can turn a simulation into
scientific insight, is a necessary component of the research
process that has often been taken for granted.
Indeed, the combination of improvements in simulation
and analysis has allowed for simulations of phenomena on
the hundreds of microseconds to millisecond timescale;17
as a high end GPU can today simulate over 100 ns/day
for a 30,000 atom system, a cluster of 100 GPUs can sim-
ulate an aggregate of 10 µs/day, yielding a millisecond of
aggregate simulation in three months. While this cluster
cannot simulate one long millisecond trajectory in three
months, MSMs allow the use of these 10-µs trajectories
to describe phenomenon on the millisecond timescale.
Markov modeling is a technology that has been rapidly
maturing for MD analysis. At least two open-source
software packages allow non-experts to construct these
models routinely,36,37 and tutorials on their use are
available.78 Nevertheless, many challenges remain in
their theory and application. In particular, parameter
selection continues to be difficult – e.g. how fine a dis-
cretization best balances competing sources of error? Re-
cent work has benefited from a synthesis of concepts from
machine learning and mathematical physics, and we an-
ticipate that the future development of Markov model-
ing will continue to be enhanced by a cross-pollination of
ideas from these communities.
Looking to the next 10 years, we expect that these
approaches will become more automated, with statisti-
cal methods replacing empirical tests of model quality
and adaptive sampling approaches maturing to the point
where they can automatically tackle a wide range of sam-
pling challenges. Moreover, in 10 years, GPUs (which
double in speed every year) will likely be 1,000 times more
powerful. The combination of these technologies suggests
that MSM simulations on the millisecond timescale will
become routine and require only a day on a modest 10-
GPU cluster, and simulations on the seconds timescale
will become within reach. At that point, the field of bi-
molecular simulation will likely be in a golden period,
where sampling is no longer the principle challenge for
many biological questions of interest.
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